Eli Lilly is a pharmaceutical company manufacturing among others, the erectile dysfunction medication “Cialis.”
Such medication is sold only via prescription in the US and many Western countries, while contraband or fake meds bearing the Cialis mark are sold on the Internet.
For that purpose, domain names using the Cialis brand are utilized in a manner that attempts to get search engine traffic.
To protect its brand and product, along with the consumers from dangerous or ineffective products, Eli Lilly has filed a massive UDRP against the owner of 218 Cialis domains.
Needless to say, that the WIPO panelist granted the transfer of all of the following domains to the Complainant:
218 Cialis domains were challenged in a UDRP by Eli Lilly.
We don’t list the domains as text as this might be regarded as spam by search engines.
To read the UDRP details, click here.
